Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,634,927 papers from all fields of science
Search
Sign In
Create Free Account
candoxatrilat
Known as:
4-((2-carboxy-3-(2-methoxyethoxy)propyl)-1-cyclopentanecarbonylamino)-1-cyclohexanecarboxylic acid
, Cyclohexanecarboxylic acid, 4-(((1-(2-carboxy-3-(2-methoxyethoxy)propyl)cyclopentyl)carbonyl)amino)-, cis-(+-)-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (2)
Cyclohexanecarboxylic Acids
Protease Inhibitors
Narrower (2)
UK 69578
UK 73967
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder.
D. Pryde
,
A. Cook
,
+14 authors
K. Beaumont
Bioorganic & Medicinal Chemistry
2007
Corpus ID: 2090994
2006
2006
Overexpression of kidney neutral endopeptidase (EC 3.4.24.11) and renal function in experimental cirrhosis.
G. Sansoè
,
M. Aragno
,
+7 authors
M. Rizzetto
AJP - Renal Physiology
2006
Corpus ID: 154766
Neutral endopeptidase degrades atrial natriuretic peptide (ANP) and bradykinin and may generate endothelin-1 from big-endothelin…
Expand
Highly Cited
1999
Highly Cited
1999
Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure.
Horng H. Chen
,
J. Schirger
,
+5 authors
J. Burnett
Circulation
1999
Corpus ID: 12192337
BACKGROUND Neutral endopeptidase 24.11 (NEP) is a metalloprotease that is localized in the greatest abundance in the kidney and…
Expand
1997
1997
Formation and pharmacokinetics of the active drug candoxatrilat in mouse, rat, rabbit, dog and man following administration of the prodrug candoxatril.
B. Kaye
,
C. Brearley
,
N. Cussans
,
M. Herron
,
M. Humphrey
,
A. R. Mollatt
Xenobiotica; the fate of foreign compounds in…
1997
Corpus ID: 28402918
1. Candoxatrilat, an active neutral endopeptidase inhibitor, was released rapidly from the inactive prodrug candoxatril in vivo…
Expand
1997
1997
Neutral endopeptidase regulates C-type natriuretic peptide metabolism but does not potentiate its bioactivity in vivo.
R. Brandt
,
M. Mattingly
,
A. Clavell
,
P. Barclay
,
J. Burnett
HYPERTENSION
1997
Corpus ID: 30651329
C-type natriuretic peptide (CNP) is a newly described 22-amino acid peptide of endothelial and renal cell origin with selective…
Expand
1997
1997
Enhanced natriuretic response to neutral endopeptidase inhibition in patients with moderate chronic renal failure.
G. Lipkin
,
A. Dawnay
,
S. Harwood
,
W. Cattell
,
A. Raine
Kidney International
1997
Corpus ID: 38933699
Atrial natriuretic factor (ANF) has natriuretic, renin-suppressing and chronic hypotensive actions that may be utilized by…
Expand
1995
1995
Natriuretic response to neutral endopeptidase inhibition is blunted by enalapril in healthy men.
J. Motwani
,
C. Lang
,
G. Cramb
,
A. Struthers
HYPERTENSION
1995
Corpus ID: 39418463
We studied six healthy male subjects in a randomized, placebo-controlled, single-blind fashion to determine the comparative…
Expand
1995
1995
Renal response to candoxatrilat in patients with heart failure.
J. Good
,
M. Peters
,
M. Wilkins
,
N. Jackson
,
C. Oakley
,
J. Cleland
Journal of the American College of Cardiology
1995
Corpus ID: 21593054
1994
1994
Inhibition of thermolysin and neutral endopeptidase 24.11 by a novel glutaramide derivative: X-ray structure determination of the thermolysin-inhibitor complex.
D. R. Holland
,
P. Barclay
,
J. Danilewicz
,
B. Matthews
,
K. James
Biochemistry
1994
Corpus ID: 2831984
Determination of the X-ray structure of thermolysin-inhibitor complexes has proven useful in aiding our understanding of the mode…
Expand
1993
1993
Renal effects of neutral endopeptidase inhibition in euvolemic and hypervolemic rats.
J. Scott
,
P. Barclay
,
N. Shepperson
European Journal of Pharmacology
1993
Corpus ID: 42938414
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE